据NeurexCorp公司报道该公司的静注用非诸多洋（fenoldopam，商品名Corlopam）获美国FDA许可用于治疗高血压。本品将用于高血压患者的住院治疗。FDA末经发布可准许信的常规中间步骤就直接批准了本品。静注用本品是Neurex公司第一个商业化产品。静注用非诺多泮获美国FDA许可 NeurexCorp reports that the company’s intravenous infusion of fenoldopam (trade name Corlopam) was approved by the U.S. FDA for the treatment of hypertension. This product will be used for hospitalization of hypertensive patients. This product was approved by the FDA directly after the usual intermediate steps to issue a letter of approval. Static Note This product is Neurex’s first commercial product. Phenylephrine is approved by the U.S. FDA for intravenous injection